Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2500083	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-03-26	Bayer Healthcare LLC	view
JYSB2500081	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-03-26	Bayer Healthcare LLC	view
JYSB2500082	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-03-26	Bayer Healthcare LLC	view
JYSB2500023	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-02-08	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2500024	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-02-08	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2500025	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-02-08	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2500026	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2025-02-08	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2400251	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-12-04	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400248	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-12-04	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400250	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-12-04	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400249	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-12-04	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
CYSB2400295	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-11-12	SinoCelltech Ltd	view
CYSB2400294	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-11-12	SinoCelltech Ltd	view
JYSB2400180	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400182	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400181	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400179	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14	Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG	view
JYSB2400155	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2400156	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16	Pfizer Europe Ma Eeig;Wyeth Farma SA	view
JYSB2400157	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-07-16	Pfizer Europe Ma Eeig;Wyeth Farma SA	view